With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Among women treated for endometrial hyperplasia, regression rates appear to be better with the levonorgestrel-releasing intrauterine system than with oral progestogen treatment, according…
NEW YORK (Reuters Health) – For women who have undergone laparoscopic surgery for severe endometriosis, ongoing chronic pelvic pain is relieved with use of the levonorgestrel-releasing intrauterine system…
NEW YORK (Reuters Health) – Training delivery ward personnel in manual assistance techniques in the crowning stage of labor significantly decreases the occurrence of anal sphincter tears, a…
NEW YORK (Reuters Health) – Results of a small study indicate that transdermal testosterone improves functional capacity and other parameters in elderly women with chronic heart failure. Writing…
NEW YORK (Reuters Health) – Weekly progesterone given to women with preterm premature rupture of membranes (PPROM) does not extend gestation and cannot be recommended, researchers report in…
NEW YORK (Reuters Health) – Pregnant women experiencing morning sickness may gain relief from Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride — the same components that…
NEW YORK (Reuters Health) – When gynecologic surgery is performed laparoscopically, the occurrence of thromboembolism is quite rare, even in patients with gynecologic malignancy, researchers report in the…
NEW YORK (Reuters Health) – Among women undergoing IVF and who respond poorly to ovarian stimulation, successful outcomes are not increased when embryo transfer takes place on day…
NEW YORK (Reuters Health) – Compared with dual therapy for HIV, highly active antiretroviral therapy (HAART) in pregnant women is associated with an increased risk of preterm delivery,…
